US Federal Senate Bill SJR84

US Federal 2025-2026 Regular Session

• Introduced: 9/30/25
• Refer: 9/30/25

Caption

A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability".

Impact

If enacted, SJR84 would mean that the regulations set forth by CMS regarding marketplace integrity and affordability would hold no force or effect. The implication of this disapproval could lead to significant alterations in how healthcare markets operate, especially regarding consumer protections and the oversight of insurance providers. By removing these regulations, there might be renewed concerns about market stability and consumer access to affordable healthcare options, particularly for vulnerable populations.

Summary

SJR84 is a joint resolution that seeks to disapprove a rule submitted by the Centers for Medicare & Medicaid Services (CMS) related to the Patient Protection and Affordable Care Act (PPACA). Specifically, the resolution targets regulations aimed at enhancing marketplace integrity and affordability in healthcare provisions. Through SJR84, Congress aims to annul these regulations, suggesting a shift in federal focus on how healthcare markets are regulated under the PPACA framework.

Sentiment

The sentiment surrounding SJR84 appears to be contentious, with clear divisions among lawmakers. Supporters argue that disapproving the CMS rule is necessary to limit overregulation and ensure that healthcare markets can function more freely. In contrast, opponents express concern that the disapproval could lead to decreased safeguards for consumers, potentially making healthcare less accessible and more unaffordable. This conflict reflects broader tensions in health policy between regulatory oversight and market freedom.

Contention

Notably, points of contention arise around the potential ramifications of eliminating these protections. Critics of the disapproval argue that such actions could exacerbate inequities in healthcare access and pricing, particularly affecting low-income and uninsured populations. Supporters counter that such regulations may impose unnecessary burdens on healthcare providers and hinder innovation in insurance offerings. Thus, the debate over SJR84 encapsulates fundamental disagreements on the role of government in healthcare regulation.